Emerging Markets Spotlight

With Covid-19 case numbers rising rapidly, James Syme reviews the portfolio's Indian exposure. 

  • James Syme
27 Apr 2021
View PDF   Download PDF  
View PDF   Download PDF  
  • The first quarter of 2021 saw Indian equities outperform the broader MSCI EM Index for the third quarter in a row, as Indian economic data and company results remained broadly supportive. 
  • However, Covid-19 data in India has worsened sharply since mid-March. 
  • We remain positive on India for our two-year investment horizon, but also remain alert to the key near-term risk that we see to that positive view.


For professional investors only. Past performance is no guarantee of future performance. The value of an investment and the income from it can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested. Investing in companies in emerging markets involves higher risk than investing in established economies or securities markets. Emerging Markets may have less stable legal and political systems, which could affect the safe-keeping or value of assets. The Fund’s investments may include shares in small-cap companies and these tend to be traded less frequently and in lower volumes than larger companies making them potentially less liquid and more volatile. The information contained herein including any expression of opinion is for information purposes only and is given on the understanding that it is not a recommendation.

For a better experience, we recommend viewing this website in landscape orientation.